MedTrace Logo

Microscopic-spectroscopic Examination for Urothelial Tissue Characterization

NCT04310813 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2020-03-18

No results posted yet for this study

Summary

To evaluate the possibility to properly discriminate between healthy bladder tissue and BCa with a multimodal fiber optic spectroscopy (MFOS) technique, in order to possibly introduce a more objective way to detect BCa, thus reducing inter-observer variability and maybe to determine urothelial carcinoma stage and grade with a comparable accuracy, specificity and sensibility of the current gold standard histopathological analysis

Conditions

  • Bladder Tumor

Interventions

DIAGNOSTIC_TEST

Multimodal spectroscopic analysis

During time of bladder or prostate resection, freshly excised cold cup biopsies of both bladder cancer or healthy bladder mucosa were taken and sent for inspection through label-free multimodal fiber optic spectroscopy (MFOS) within 30 minutes

Sponsors & Collaborators

  • Careggi Hospital

    lead OTHER

Principal Investigators

  • Simone Morselli, MD · University of Florence

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2019-12-01
Completion
2020-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04310813 on ClinicalTrials.gov